AIRLINK 88.80 Decreased By ▼ -0.90 (-1%)
BOP 4.84 Decreased By ▼ -0.12 (-2.42%)
CNERGY 3.96 Decreased By ▼ -0.07 (-1.74%)
DFML 40.15 Decreased By ▼ -0.41 (-1.01%)
DGKC 90.25 Decreased By ▼ -0.15 (-0.17%)
FCCL 22.99 Decreased By ▼ -0.10 (-0.43%)
FFBL 33.50 Decreased By ▼ -0.80 (-2.33%)
FFL 9.14 Increased By ▲ 0.06 (0.66%)
GGL 9.91 Decreased By ▼ -0.03 (-0.3%)
HASCOL 6.05 Decreased By ▼ -0.04 (-0.66%)
HBL 125.62 Decreased By ▼ -1.37 (-1.08%)
HUBC 163.72 Decreased By ▼ -1.53 (-0.93%)
HUMNL 10.77 Decreased By ▼ -0.06 (-0.55%)
KEL 4.41 Decreased By ▼ -0.11 (-2.43%)
KOSM 4.23 Decreased By ▼ -0.11 (-2.53%)
MLCF 38.00 Increased By ▲ 0.10 (0.26%)
OGDC 128.81 Decreased By ▼ -3.37 (-2.55%)
PAEL 24.85 Decreased By ▼ -0.02 (-0.08%)
PIBTL 6.14 Increased By ▲ 0.06 (0.99%)
PPL 116.66 Decreased By ▼ -1.58 (-1.34%)
PRL 24.15 Decreased By ▼ -0.15 (-0.62%)
PTC 12.00 Decreased By ▼ -0.15 (-1.23%)
SEARL 57.92 Decreased By ▼ -0.53 (-0.91%)
SNGP 64.25 Decreased By ▼ -0.30 (-0.46%)
SSGC 9.66 Decreased By ▼ -0.10 (-1.02%)
TELE 7.60 Decreased By ▼ -0.07 (-0.91%)
TPLP 8.98 Decreased By ▼ -0.20 (-2.18%)
TRG 62.80 Decreased By ▼ -0.60 (-0.95%)
UNITY 29.66 Increased By ▲ 2.49 (9.16%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 8,246 Decreased By -46.1 (-0.56%)
BR30 26,414 Decreased By -199.7 (-0.75%)
KSE100 77,941 Decreased By -291.5 (-0.37%)
KSE30 25,187 Decreased By -117 (-0.46%)

Anvisa

Russia's Sputnik V developers to sue Brazilian regulator for 'false information' about their vaccine
Business & Finance

Russia's Sputnik V developers to sue Brazilian regulator for 'false information' about their vaccine

  • The board of Brazilian health regulator on Monday rejected importing Sputnik V after technical staff warned of flaws in its development along with incomplete data regarding the vaccine's safety and efficacy.
  • A crucial issue for the Brazilian regulator was the risk of other viruses used to make the vaccine reproducing in patients, which an Anvisa expert had called a "serious" defect.
Updated 29 Apr, 2021 07:46pm
Brazil gives final approval for AstraZeneca vaccine, sees domestic manufacture
World

Brazil gives final approval for AstraZeneca vaccine, sees domestic manufacture

  • The AstraZeneca vaccine is already being administered in Brazil, but is registered only for emergency use, and the doses have been imported from India.
  • In an online address, Anvisa director Gustavo Mendes said that the doses manufactured by Fiocruz are expected to be delivered to the Health Ministry later this month.
Published 12 Mar, 2021 08:40pm
Brazil approves Pfizer's COVID-19 shot, but has none to use
Business & Finance

Brazil approves Pfizer's COVID-19 shot, but has none to use

  • The Pfizer/BioNTech shot is the first vaccine against the novel coronavirus to receive full approval in Brazil, Anvisa said. Other vaccines developed by AstraZeneca and China's Sinovac Biotech Ltd, have only been approved for emergency use so far.
  • The approval is good news for a country whose immunization campaign has been plagued by delays and political squabbling.
Published 23 Feb, 2021 07:44pm